Inflammation is a key contributor to the pathogenesis of bronchopulmonary dysplasia (BPD)
in preterm infants, and cortisol plays a central role in controlling inflammation. Insufficient …

Antenatal glucocorticoid has proven to be one of the most successful single therapeutic
approaches for preventing serious consequences after preterm birth. The fetal compartment …

Infants born in the late preterm period and via non-labour caesarean section in the early
term period are at increased risk of respiratory morbidity when compared to their term-born …

Background. Infants developing bronchopulmonary dysplasia (BPD) show decreased
cortisol response to adrenocorticotropic hormone. A pilot study of low-dose hydrocortisone …

Background: Corticosteroids have been used widely after birth in preterm infants with
respiratory failure; hydrocortisone may be preferable to other corticosteroids for this purpose …

Bronchopulmonary dysplasia (BPD) is a chronic lung disease commonly affecting extremely
preterm infants. Although mechanical ventilation and oxygen requirements in premature …

Antenatal corticosteroids for women at risk of preterm delivery is one of the most important
interventions described to date to reduce morbidity and mortality in preterm newborns. First …

Numerous investigations have indicated that antenatal corticosteroid administration reduces
neonatal morbidity in preterm infants. Despite this, antenatal corticosteroid usage continued …

A single course of antenatal corticosteroids is a rare example of a treatment that yields both
a health benefit and a cost savings. This article reviews the history and background of …

Antenatal glucocorticoid therapy remains one the most striking successes in perinatal
management of complicated pregnancies leading to premature birth. All women at risk of …